Appointment of New Distributor in Thailand
4 November 2019
The REPROCELL group has signed a non-exclusive distributorship agreement with A.N.H. Scientific Marketing Co. Ltd. to distribute REPROCELL’s products and services in Thailand.
Lantern Pharma Selects REPROCELL Inc. to Provide Preclinical Screening and Biomarker Discovery Services for Portfolio of Targeted Oncology Drugs
29 October 2019
Lantern Pharma announced today that it has selected REPROCELL to provide preclinical screening and drug sensitivity work for its portfolio of oncology drugs.
PRESS RELEASE: REPROCELL and NeuCyte enter distribution agreement in North America and Europe
25 September 2019
Yokohama, Japan, & San Carlos, California, USA — REPROCELL, Inc., and NeuCyte, Inc., today announced a new distributorship.
PRESS RELEASE: Axion BioSystems make REPROCELL a product distributor
28 August 2019
Axion BioSystems, Inc., the world leader in multi-well microelectrode array (MEA) systems, has announced REPROCELL as the new distributor of its Maestro systems and consumables in Japan.
PRESS RELEASE: ABLE Biott Bioreactors now available in Europe
22 August 2019
Glasgow, UK: REPROCELL Europe Ltd today announced exclusive distribution rights to a single-use reactor series for stem cell culture in 11 European countries.
ELRIG Drug Discovery 2019
5-6 November 2019 / Liverpool, UK
REPROCELL will join more than 1200 Drug Discovery Scientists. Stop by Booth D9 to visit us.
ISSCR Toronto: From Stem Cell Biology to New Therapies
6-8 November 2019 / The Metro Toronto Convention Centre, Ontario Canada
REPROCELL is sponsoring this symposium about clinical applications of stem cell therapies. REPPROCELL’s Duncan Liew, Rao Mahendra and Daniel Haus will be in attendance. Stop by Booth 6 to find out about our clinical-grade iPSC services.
What are the advantages of an internship to employers?
23 October 2019
Why do companies hire interns? In this post, we will describe 4 ways that hiring an intern can benefit your employees and business.
5 factors to consider when planning a stem cell reprogramming project
17 October 2019
When you are planning a project involving stem cell reprogramming, there are several factors to consider when choosing a reprogramming technology and a service provider. This post will highlight 5 questions you may want to answer before choosing a service provider or reprogramming technology.
How to improve your 3D Cell Culture using Small-scale Perfusion Systems
07 October 2019
In this post, we will explore two examples of how perfusion systems can help take your 3D cell culture one step further.
The Gut Microbiome and its Role in Inflammatory Bowel Disease
01 October 2019
The microbiome is linked to the pathogenesis of Inflammatory Bowel Disease. Could this be the next big focus for precision medicine?
REPROCELL and NeuCyte enter distribution agreement in North America and Europe
25 September 19
This new distributorship will grant REPROCELL customers access to NeuCyte's pure and ready-to-use iPSC-derived glutamatergic and GABAergic induced neurons.
The Big Data Dilemma
16 September 2019
Combining patient and drug discovery data to transform healthcare. REPROCELL’s R&D project aims to combine medical history with tissue response.
Our Popular Products